THE SCHEDULE 13G

Company

FATE THERAPEUTICS INC

Filed

December 1, 2016

Accession Number

0000921895-16-006259

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →